Therapex Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Holding
- Established
- 2020-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://therapexbio.net
A Study to Investigate Safety, Tolerability, PK and Anti-tumor Activity of TRX-221 in EGFRm NSCLC Patients
Phase 1
Recruiting
- Conditions
- Carcinoma, Non-Small-Cell LungEGFR Mutant Advanced Non-Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2023-12-29
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- Therapex Co., Ltd
- Target Recruit Count
- 115
- Registration Number
- NCT06186076
- Locations
- 🇰🇷
Chungbuk National University Hospital, Chungju, Chungbuk, Korea, Republic of
🇰🇷Seoul National University Bundang Hospital, Seongnam, Kyeongki, Korea, Republic of
🇰🇷Severance Hospital, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath